GLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ GenesGLP-3 R Phase 2: −28.7%143 Compounds · 5 Layers>98% HPLC All VialsFree Shipping $200+Third-Party Test ReportsResearch Use OnlyCAS Numbers VerifiedGHK-Cu: 4,000+ Genes
5-Amino-1MQ 50mg
Popular

5-Amino-1MQ 50mg

5-Amino-1-methylquinolinium

CAS: 1482516-78-0

$71.99$79.9910% OFFIn Stock

5-Amino-1MQ is a small-molecule CD38 inhibitor that blocks the primary NAD-consuming enzyme. By inhibiting CD38, it raises intracellular NAD+ levels, activating sirtuins and improving mitochondrial function. Research shows fat mass reduction and improved metabolic parameters. 99.0% HPLC purity.

Specifications

Vial Size50mg
FormLyophilized Powder
Purity99.0% HPLC
CAS1482516-78-0
Storage-20C long-term
Shop This Compound

For laboratory research use only. Not for human consumption.

Mechanism of Action

Selective CD38 NADase inhibition increases intracellular NAD+, activating SIRT1/SIRT3 deacylases. Downstream effects include PGC-1a upregulation, mitochondrial biogenesis, and reduced adipogenesis via PPAR-gamma inhibition.

Research FAQ

How does 5-Amino-1MQ raise NAD+?

It inhibits CD38, the dominant NAD-consuming enzyme. CD38 activity accounts for up to 60% of NAD+ consumption — blocking it produces a rapid rise in intracellular NAD+, amplifying sirtuin activity downstream.

Related Compounds